Multiple trials have reported on outcomes comparing CABG and PCI for the treatment of left main coronary disease.
Multiple trials have reported that impaired kidney function augments the levels of these natriuretic peptides but the optimal cutoffs are not well known with various patients' population.
Both trials reported multiple dose adverse effects.
For trials reported in multiple publications we used the most recent publication.
Twenty-four (29%) trials reported data for multiple intervention groups, 30 (36%) reported data for multiple time points, and 29 (35%) reported the index outcome measured on multiple scales.
45 54 57 When trials reported outcomes at multiple time points, we analysed the longest follow-up; most studies lasted about one year.
Where trials reported retention at multiple time points, without specifying which one was the primary outcome, we used the earliest time point in the analysis to see the initial impact on retention or response of introducing the strategy.
Among the 21 trials, 13 trials reported average volume of maximum fibroids, two trials reported total volume of multiple fibroids, four trials reported average volume of multiple fibroids, and two trials reported average diameter of fibroids.
No trials reported on QoL.
Similar proportion of trials reported clinical benefit.
